Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.51B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$985M |
| 3 |
Apple
AAPL
|
+$890M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$774M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$736M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$673M |
| 2 |
Bank of America
BAC
|
+$615M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$515M |
| 4 |
NVIDIA
NVDA
|
+$451M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$417M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.95% |
| 2 | Financials | 8.18% |
| 3 | Consumer Discretionary | 7.81% |
| 4 | Healthcare | 7.12% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3976
Vitamin Cottage Natural Grocers
NGVC
$654M
| $361K | ﹤0.01% |
22,534
+11,604
| +106% | +$169K |
|
3977
Tilly's
TLYS
$128M
| $360K | ﹤0.01% |
47,801
+26,718
| +127% | +$215K |
|
3978
Vermilion Energy
VET
$1.66B
| $360K | ﹤0.01% |
29,841
+169
| +0.6% | +$2.24K |
|
3979
Noodles & Co
NDLS
$107M
| $360K | ﹤0.01% |
14,269
+6,024
| +73% | +$132K |
|
|
DOO
3980
Bombardier Recreational Products
DOO
$4.77B
| $359K | ﹤0.01% |
5,014
+4,043
| +416% | +$283K |
|
3981
PUT
BioCryst Pharmaceuticals
BCRX
$2.4B
| $359K | ﹤0.01% |
+60,000
| New | +$348K |
|
3982
Camtek
CAMT
$7.25B
| $358K | ﹤0.01% |
5,167
-58
| -1% | -$3.53K |
|
3983
Rigel Pharmaceuticals
RIGL
$750M
| $357K | ﹤0.01% |
24,650
+20,485
| +492% | +$209K |
|
3984
Waterstone Financial
WSBF
$375M
| $357K | ﹤0.01% |
25,132
+20,811
| +482% | +$246K |
|
|
TSVT
3985
DELISTED
2seventy bio
TSVT
| $357K | ﹤0.01% |
83,552
+40,434
| +94% | +$124K |
|
3986
Genelux
GNLX
$119M
| $357K | ﹤0.01% |
25,465
+22,081
| +653% | +$349K |
|
3987
Motorcar Parts of America
MPAA
$258M
| $357K | ﹤0.01% |
38,182
+23,664
| +163% | +$200K |
|
3988
PUT
Honeywell
HON
$78B
| $357K | ﹤0.01% |
+1,804
| New | +$325K |
|
3989
Aemetis
AMTX
$124M
| $356K | ﹤0.01% |
67,995
+31,774
| +88% | +$150K |
|
|
NXDT
3990
NexPoint Diversified Real Estate Trust
NXDT
$238M
| $355K | ﹤0.01% |
44,642
+39,225
| +724% | +$321K |
|
3991
CALL
BP
BP
$107B
| $354K | ﹤0.01% |
+10,000
| New | +$366K |
|
3992
EverCommerce
EVCM
$1.93B
| $354K | ﹤0.01% |
32,054
+27,445
| +595% | +$265K |
|
3993
Medallion Financial
MFIN
$250M
| $353K | ﹤0.01% |
35,865
+27,783
| +344% | +$231K |
|
|
MRSN
3994
DELISTED
Mersana Therapeutics
MRSN
| $353K | ﹤0.01% |
6,083
+4,717
| +345% | +$190K |
|
3995
Choiceone Financial
COFS
$510M
| $352K | ﹤0.01% |
12,018
+8,224
| +217% | +$192K |
|
3996
Arcutis Biotherapeutics
ARQT
$3.18B
| $351K | ﹤0.01% |
108,660
-98,417
| -48% | -$268K |
|
3997
Neumora Therapeutics
NMRA
$302M
| $350K | ﹤0.01% |
+20,539
| New | +$252K |
|
3998
Celcuity
CELC
$4.52B
| $350K | ﹤0.01% |
24,021
+20,830
| +653% | +$252K |
|
3999
Invesco Solar ETF
TAN
$1.49B
| $349K | ﹤0.01% |
6,550
-14,790
| -69% | -$693K |
|
|
JBIO
4000
Jade Biosciences
JBIO
$1.34B
| $348K | ﹤0.01% |
440
+330
| +300% | +$168K |
|
Similar funds
Barclays's Q4 2023 Portfolio in Review
As of Q4 2023, Barclays held 5,469 positions worth $273B, up 70% from $161B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Barclays deployed $85.1B of net new capital in Q4 2023, opening 898 new positions and adding to 2,915 existing holdings. Its largest new stake was AngloGold Ashanti: 9,667,894 shares worth $181M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 27% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $673M trimmed.
- Barclays's largest Q4 2023 buy was AngloGold Ashanti: 9,667,894 shares worth $181M.
- Barclays added most to Meta Platforms (Facebook) in Q4 2023, an estimated $1.51B increase.
- Barclays's biggest Q4 2023 reduction was CRH, cutting an estimated $673M.
- Barclays fully exited Activision Blizzard in Q4 2023, selling an estimated $417M.
- Barclays's ten largest holdings make up 27% of its $273B portfolio in Q4 2023.
- Barclays opened 898 new positions and closed 253 in Q4 2023.
- Barclays's portfolio value rose 70% quarter-over-quarter to $273B.
Based on Barclays's 13F filing for Q4 2023, filed 15 Feb 2024.